Acinetobacte is a non-fermenting gram-negative bacillus that has so far identified more than 30 species in the genus Acinetobacte. Most of these species are environmental bacteria and are not associated with human infections. A. baumannii, A. calcoaceticus, and A. lwoffii are the most common species associated with human infections. Also, A. junii has recently been isolated
as an opportunistic pathogen in cancer patients (
14).
Outer membrane protein A (OmpA) (making biofilm), polysaccharide capsule (anti-complement activation agent), and fimbriae (attachment agent) are the most important virulence factor which confers high resistance to the harsh environment (
15).
Acinetobacte species, especially
A. baumannii, are important pathogens of nosocomial infections with high mortality.
A. baumannii is a major health problem, especially in the ICU and NICU wards, and can infect these wards for a long time and involve immunocompromised patients (
16).
In the present study, 100 non –repetitive
A. baumannii isolates were collected from a teaching hospital in Ardabil province. Isolates were recovered from patients admitted to ICU sector and also, hypertension, duration of hospitalization, and gender of patients were the most important predisposing factors to
A. baumannii infections, which was consistence with another study in Iran and china (
17,
18).
A. baumannii uses different mechanisms to develop resistance to different classes of antibiotics and is approximately resistant to a wide range of antibiotics. Over the past decades, MDR strains have increased, and treatment options for treating infections caused by the bacterium have increasingly dropped. Three main mechanisms have been identified that mediated resistance to quinolones: (1) mutation in antibiotic target (2) efflux pump (3) Qnr protein plasmid.
The most common known mechanism for resistance to quinolones in gram-negative bacilli is mutations in the target enzyme, including DNA gyrase and topoisomerase IV, encoded by the gyrA and gyrB, parC, and parE genes, respectively. In
A. baumannii, rapid resistance to ciprofloxacin and nalidixic acid associated with chromosomal mutations in the Quinolone resistance determining regions (QRDRs) are from the gyrA and parC genes (
11).
Changes in the efflux pump lead to resistance to a wide range of antibiotics, including tetracycline, chloramphenicol, fluoroquinolones, and trimethoprim. Quinolones are bacteriostatic antibiotics targeting the enzyme DNA gyrase, inhibiting DNA replication and transcription (
19).
The aim of the present study was to investigate the prevalence of the MDR strain of A. baumannii and determine of involved mechanisms of resistance to fluoroquinolone in clinical isolates of A. baumannii taken from patients admitted to teaching hospitals in the Ardabil province of the northwest of Iran. Therefore we assessed the presence of mutations in the gyrA and parC genes and the presence of plasmid-resistance genes, including the Ib-cr aac gene, qnrA, and qepA.
A single substitution (S83L) in the gyrA gene and
the presence of Ib-cr aac were detected in isolates with high MIC to ciprofloxacin (≤ 1024). Single amino acid substitution in GyrA (Ser83Leu) and ParC (Ser80Leu) are associated with high-level resistance to ciprofloxacin and nalidixic acid
Two isolates that were recovered from the trachea and catheter had high MIC to ciprofloxacin (≤ 1024)
which were screened for gyrA, parC, and PMQR genes by PCR and sequencing in which mutations in the gyrA gene and the presence of aac(6′)-Ib-cr resistance gene were detected, respectively. qnrA and qepA genes were not found in the two isolates.
Qnr A, aac(6′)-Ib-cr and qepA are plasmid-mediated fluoroquinolone resistance genes, and the presence of these genes increases the MICs of ciprofloxacin.
qnrA encodes a protein that protects topoisomerase II from quinolones, and AAC (6′)-Ib-cr gene encodes an aminoglycoside acetyltransferase which modifies quinolone drugs.
qepA gene is related to the expression of the active efflux pump (
20). Plasmid-mediated quinolone resistance (PMQR) is the group of genes associated with decreasing susceptibility to quinolones such as norfloxacin and ciprofloxacin (
12).
In this study, the frequency of MDR isolates was 99%, and the study of 3 classes of integrons showed that the frequency of class 1 integrons is high, which in turn plays an important role in the greater and easier spread of antibiotic resistance. Cassette 1 sequencing showed the presence of the aadA1 gene encodes
aminoglycoside 3''-O-nucleotidyltransferase, which confers resistance to the aminoglycoside antibiotics such as streptomycin and spectinomycin (
21). The results of this study indicated that a single substitution (S83L) in gyrA gene and Ib-cr aac play a major role in conferring a high level of resistance to ciprofloxacin.
In our study, the resistance ratio to each tested antimicrobial agent was over 90%, and only polymixin B was able to eliminate resistant isolates. Despite previous studies, in this study, the resistance rate to imipenem and meropenem was very high (
22).
Integrons can carry different cassettes that confer resistance to several classes of antibiotics. In this study, 70% of the isolates had class 1 integrons, 21% had class 2 integrons, and no class 3 integrons were identified. Casstte array of integron 1 showed aadAgene. In another study in northwest Iran, the prevalence rate of class 1 integron in multidrug-resistant
Acinetobacte baumannii (MDRAB) clinical isolates was 92.5% (
23).
In a study conducted by Goodarzi et al. in Tehran, the resistance rate among isolates was between 39.3% and 99.1%, and similar to our study, no resistance to polymyxin B was observed (
24). In this study, the resistance rate to imipenem and meropenem was 99.1% and 62.5%, unlike another similar study in Tehran, the resistance rate for imipenem was 4.5% (
25). Consistency with Goodarzi's study: In our study, the resistance rate to carbapenems was more than 98%, which is remarkable.
During the past decades, the prevalence of multidrug and extensively drug resistant A. baumannii strain has become a serious threat in hospital setting. So recently, this bacterium has been one of the most important causes of ventilator-associated pneumonia and sepsis in patients in intensive care and neonatal intensive care units. The bacterium's resistance to harsh environmental conditions, antibiotics, and disinfectants and its association with fatal nosocomial infections have made it a serious threat. Integrons are mobile genetic elements that confer resistance to the different classes of antibiotics through a horizontal gene transfer pathway. Structurally, they can obtain different cassettes which encode different antibiotic-destroying enzymes and have a critical role in antibiotic resistance distribution among different species of bacteria. Recently, the relationship between multiple drug resistance, MDR strain, and integrons is well documented.
In the present study, the trachea was the main
A. baumannii isolation source (56%) which was in accordance with previous studies in which respiratory specimens are prominent (
26).
Although Carbapenems such as imipenem and meropenem are the drug of choice for the treatment of serious nosocomial infections caused by
Acinetobacte, carbapenem-resistant strains are increasingly encountered. However, the distribution of carbapenem-resistant strains of AB differs over the different geographical regions. At present, the resistance rate to carbapenems is higher than the other country like Turkey (80%) (
27), Germany 3.5% (
28), and Russia (45%) (
29). In critical conditions, combination therapy such as meropenem/colistin has been recommended (
30).
This study showed that in Ardabil province, such as in other parts of Iran, there is high antibiotic resistance among A. baumannii strains, and all strains are MDR.also, more than half of the strains and one-third of them harboring integron class 1 and 2, respectively. The most common site of A. baumannii isolation was the ICU sector which requires more attention to this ward
and the patients hospitalized in this site.
5.1. Conclusions
In the past few years, carbapenems have been the most effective drug against antibiotics, but the results of this study show that the resistance rate for carbapenemase in teaching hospitals in Ardabil has reached an alarming state. As a result of prolonged exposure to these valuable drugs and the use of inappropriate doses, resistance has developed initially. Therefore appropriate use of effective antibiotics, multiple drug combinations, and isolation of infected patients with drug-resistant strains in hospitals from the rest of the patients may help control the emergence of resistance.